Abstract | OBJECTIVE: • To determine the actual recurrence risk of patients with a Gleason score (GS) ≤ 6 treated with radical retropubic prostatectomy (RRP) and bilateral lymphadenectomy in a cohort with long-term follow-up. PATIENTS AND METHODS: • The USC/Norris Comprehensive Cancer Center database included 3235 consecutive patients who underwent RRP for prostate cancer between January 1972 and December 2005. We identified 1383 patients with a GS ≤ 6 in prostatectomy specimens. Median follow-up was 8.3 years. Data on pathological and clinical characteristics and outcome were prospectively recorded. • Statistical analysis was performed using the stratified log-rank test and stepwise Cox regression analysis. RESULTS: • A GS of 6 was present in 66%, 5 in 27%, 4 in 5% and 3 or 2 in 3% of cases. Tumour classification was pT2N0 (83%), pT3N0 (14%), pT4N0 (0.1%) and any TN1 (2%). • Positive margins were seen in 18%. Estimated PSA and clinical recurrence rate were 14% and 4% after 10 years and 18% and 6% after 15 years, respectively. In multivariate analysis, N-stage (P < 0.001), T-stage (P= 0.02) and margin status (P < 0.001) were associated with PSA recurrence. • N-stage (P < 0.001) and T-stage (P= 0.01) were associated with clinical recurrence. • Overall, patients with a GS ≤ 6 accounted for 26% of all PSA recurrences and for 20% of all patients with clinical recurrences in the database. CONCLUSION: • A relatively small proportion of patients with a GS ≤ 6 cancer developed PSA recurrence and/or overt metastasis. However, these patients account for a substantial minority of those who experienced recurrence and metastasis.
|
Authors | Marc Birkhahn, David F Penson, Jie Cai, Susan Groshen, John P Stein, Gary Lieskovsky, Donald G Skinner, Richard J Cote |
Journal | BJU international
(BJU Int)
Vol. 108
Issue 5
Pg. 660-4
(Sep 2011)
ISSN: 1464-410X [Electronic] England |
PMID | 21223479
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | © 2010 THE AUTHORS. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL. |
Topics |
- Adult
- Aged
- Aged, 80 and over
- Biopsy, Needle
- Disease-Free Survival
- Follow-Up Studies
- Humans
- Lymph Node Excision
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(pathology, surgery)
- Neoplasm Staging
- Prognosis
- Prostatectomy
(methods)
- Prostatic Neoplasms
(pathology, surgery)
- Risk Factors
- Time Factors
- Treatment Outcome
|